Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS

Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer. In addition, two new laser systems for the physician-office and surgery center will be introduced.

A Breakfast Symposium will be held on Tuesday, October 6th, 2009, entitled "Controversies in Management of Laryngeal Cancer: The Emerging Roles of Endoscopic Resection and Radiation Therapy" and will be moderated by Dr. Mark S. Courey of University of California, San Francisco, Director of the Division of Laryngology. Two laser surgeons and radiation oncologists will engage in a constructive debate about various treatment modalities.

"We are pleased to provide an educational forum in this important arena," said Mr. Dov Ofer, Lumenis' Chief Executive Officer. "Transoral Laser Microsurgery (TLM) and Radiation Therapy are major options in the physician's armamentarium to manage laryngeal and oral-pharyngeal cancers. We look forward to the panel's discussion on the latest findings which indicate that automated and robotic CO2 laser systems achieve superior results."

"New and advanced laser systems have made much of the difference," commented Dr. Paul Castellanos, Associate Professor of Surgery, Laryngology-Bronchoesophagology, University of Alabama at Birmingham. "The UltraPulse SurgiTouch CO2 Laser with the Digital AcuBlade (DAB) microsurgery system allows me to achieve unparalleled levels of precision, low thermal damage and treatment reproducibility. The DAB automatically carries out laser incisions and ablations that allow me to recognize margins better, which is especially important in TLM for airway stenosis (narrowing) where collateral tissue damage is a matter of life and death."

Mr. Lloyd Diamond, Senior Vice President and General Manager of Lumenis' Surgical Business Unit adds, "Not only is there the clinical benefit of TLM, but also the cost comparison to Radiation Therapy is compelling. Simply put, TLM is a more economic approach with equal or superior results, an important factor in today's health care system environment."

New products for the office or surgery center

Lumenis is introducing two new laser systems for use in the physician's office and surgery center:

  • AcuPulse 40ST is a compact CO2 laser, which includes integrated video support and the popular SurgiTouch automation system
  • FOX 980 is a portable and affordable fiber delivered diode laser specifically designed for nasal, oro-pharyngeal and general ENT applications in an office environment

"The flexibility of the FOX 980 Diode Laser is amazing," said Dr. Yosef Krespi, Clinical Professor of Otolaryngology, Columbia University. "In my busy practice it is routinely used for such common indications like turbinate hyperplasia, epistaxis, tonsilar cysts and stones, nasal synechia, snoring and septal spur reduction etc. and I can easily carry this small system to various office locations."

Source:

Lumenis

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lumenis Inc.. (2019, June 19). Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS. News-Medical. Retrieved on January 24, 2020 from https://www.news-medical.net/news/20090930/Lumenis-to-discuss-different-treatment-options-for-laryngeal-cancer-at-2009-AAO-HNS.aspx.

  • MLA

    Lumenis Inc.. "Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS". News-Medical. 24 January 2020. <https://www.news-medical.net/news/20090930/Lumenis-to-discuss-different-treatment-options-for-laryngeal-cancer-at-2009-AAO-HNS.aspx>.

  • Chicago

    Lumenis Inc.. "Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS". News-Medical. https://www.news-medical.net/news/20090930/Lumenis-to-discuss-different-treatment-options-for-laryngeal-cancer-at-2009-AAO-HNS.aspx. (accessed January 24, 2020).

  • Harvard

    Lumenis Inc.. 2019. Lumenis to discuss different treatment options for laryngeal cancer at 2009 AAO-HNS. News-Medical, viewed 24 January 2020, https://www.news-medical.net/news/20090930/Lumenis-to-discuss-different-treatment-options-for-laryngeal-cancer-at-2009-AAO-HNS.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service